IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on August 11, 2026

Aug. 11, 2026

Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma

Indeterminate GlobeNewswire

Aug. 11, 2026

AXIL Brands Schedules Fiscal Fourth Quarter and Full Year 2026 Earnings Release and Conference Call for August 18

Indeterminate GlobeNewswire

Aug. 11, 2026

Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Arctera™ Unified Platform Expands Capabilities to Strengthen Defensible Compliance

Indeterminate GlobeNewswire

Aug. 11, 2026

IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Rocket Doctor Expands In-Network Access for More Than 100,000 Additional Eligible Members in New York

Indeterminate GlobeNewswire

Aug. 11, 2026

Courser Ranked No. 957 on the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies

Indeterminate GlobeNewswire

Aug. 11, 2026

SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma

Indeterminate GlobeNewswire

Aug. 11, 2026

 Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…

Indeterminate GlobeNewswire

Aug. 11, 2026

K2 Therapeutics Appoints Dr. Ying Huang as Chief Executive Officer and Announces $50 Million Seed Financing

Indeterminate GlobeNewswire

Aug. 11, 2026

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Indeterminate GlobeNewswire

Aug. 11, 2026

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States

Indeterminate GlobeNewswire

Aug. 11, 2026

TripleDart tops $7 million ARR with AI-led growth, reports 50 per cent EBIT margin

Indeterminate GlobeNewswire

Aug. 11, 2026

Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 11, 2026

Intermap Appoints J. Michael Rolland to Board of Directors

Indeterminate GlobeNewswire

Aug. 11, 2026

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Indeterminate GlobeNewswire

Aug. 11, 2026

ZenaTech’s ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities

Indeterminate GlobeNewswire

Aug. 11, 2026

TechnoMile’s Five-Year Sustained Growth Recognized with Place on the 2026 Inc. 5000 List

Indeterminate GlobeNewswire

Aug. 11, 2026

Microchip Advances Edge AI Sensor Connectivity with Rev 2.0 PolarFire® FPGA Ethernet Sensor Bridge

Indeterminate GlobeNewswire